Multifocal Motor Neuropathy with Conduction Block: Current Issues in Diagnosis and Treatment

Seminars in Neurology

Volumn 23, Issue 3, 2003, Pages 325-333

  Nagale, Smriti V ^a   Bosch, E Peter ^a  

^a MAYO CLINIC   (United States)

Author keywords

Diagnosis; Multifocal motor neuropathy with conduction block; Treatment

Indexed keywords

BETA1A INTERFERON; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M ANTIBODY; RITUXIMAB;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ALOPECIA; ANAPHYLAXIS; ANTIBODY TITER; ASEPTIC MENINGITIS; ATROPHY; AUTOIMMUNE DISEASE; BREATHING DISORDER; CASE REPORT; CHILL; CONGESTIVE HEART FAILURE; DEEP VEIN THROMBOSIS; ELECTROPHYSIOLOGY; FEVER; FLU LIKE SYNDROME; HEADACHE; HEART INFARCTION; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; HYPERREFLEXIA; HYPONATREMIA; IMMUNE COMPLEX DISEASE; LONG TERM CARE; LUNG EMBOLISM; MALE; MIGRAINE; MOTOR NERVE CONDUCTION; MOTOR NEUROPATHY; MOTOR PERFORMANCE; MULTIFOCAL MOTOR NEUROPATHY; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYALGIA; NAUSEA; NERVE BLOCK; NEUTROPENIA; PETECHIA; PHYSICAL EXAMINATION; PRION DISEASE; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; REVIEW; SIDE EFFECT; SPASTICITY; STROKE; THORAX PAIN; URTICARIA; VOMITING;

ADULT; ATROPHY; AUTOIMMUNE DISEASES; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; ELECTROPHYSIOLOGY; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; MOTOR NEURON DISEASE; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PROGNOSIS;

EID: 0346847756     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-814745     Document Type: Review

References (66)

1. Rowland LP, Sneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688-1700
2. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118:707-719
3. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch Neurol 2000;57:1171-1176
4. Van den Berg-Vos RM, Visser J, Franssen H, et al. Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain 2003;126:1037-1047
5. Katz JS, Wolfe GI, Andersson PB, et al. Brachial amyotrophic diplegia: a slowly progressive motor neuron disease. Neurology 1999;53:1071-1076
6. Pestronk A. Multifocal motor neuropathy: diagnosis and treatment. Neurology 1998;51:S22-S24
7. Chaudhry V. Multifocal motor neuropathy. Semin Neurol 1998;18:73-81
8. Nobile-Orazio E. Multifocal motor neuropathy. J Neuroimmunol 2001;115:4-18
9. Parry GJ. AAEM case report #30: multifocal motor neuropathy. Muscle Nerve 1996;19:269-276
10. Pringle CE, Belden J, Veitch JE, Brown WF. Multifocal motor neuropathy presenting as ophthalmoplegia. Muscle Nerve 1997;20:347-351
11. Kaji R, Shibasaki H, Kimura J. Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology 1992;42:506-509
12. Magistris M, Roth G. Motor neuropathy with multifocal persistent conduction blocks. Muscle Nerve 1992;15:1056-1057
13. Dumitru D. Electrodiagnostic Medicine. Philadelphia: Hanley & Belfus; 1995
14. Taylor B, Wright A, Harper C, Dyck P. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve 2000;23:900-908
15. Katz JS, Wolfe GI, Bryan WW, et al. Electrophysiologic findings in multifocal motor neuropathy. Neurology 1997;48:700-707
16. Van Asseldonk JTH, Van den Berg LH, Van den Berg-Vos RM, Wieneke GH, Wokke JH, Franssen H. Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness. Brain 2003;126:186-198
17. Grant IA, Gruener G, Suarez GA, Litchy WJ, Dyck PJ. Focal fiber loss and axonal regeneration is prominent in multifocal motor neuropathy with conduction block. Can J Neurol Sci 1996;1:S11
18. Kaji R, Nobuyaki O, Teruyuki T, et al. Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 1993;33:152-158
19. Van Es HW, Van den Berg LH, Franssen H, et al. Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 1997;48:1218-1224
20. Corse A, Chaudhry V, Crawford T, Cornblath D, Kuncl R, Griffin J. Sensory nerve pathology in multifocal motor neuropathy. Ann Neurol 1996;39:319-325
21. Willison H, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002;125:2591-2625
22. Brahe C, Servidei S, Zappata S, Ricci E, Tonali P, Neri G. Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy. Lancet 1995;346:741-742
23. La Spada AR, Roling DB, Harding AE, et al. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet 1992;2:301-304
24. Mouton P, Tardieu S, Gouider R, et al. Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology 1999;52:1440-1446
25. Simmons Z, Mahadeen ZI, Kothary NJ. Localized hypertrophic neuropathy: magnetic resonance imaging findings and long-term follow up. Muscle Nerve 1999;22:28-36
26. Saperstein DS, Amato AA, Wolfe GI, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 1999;22:560-566
27. Lewis R, Sumner A, Brown M, Asbury A. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32:958-964
28. Carpo M, Cappellari A, Mora G, et al. Deterioration of multifocal motor neuropathy after plasma exchange. Neurology 1998;50:1480-1482
29. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-78
30. Van den Berg LH, Lokhorst H, Wokke JHJ. Pulsed high dose dexamethasone is not effective in patients with multifocal motor neuropathy. Neurology 1997;48:1135
31. Donaghy M, Mills KR, Boniface SJ, et al. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994;57:778-733
32. Kuntzer T, Steck AJ, Adams D, Regli F. Chlorambucil fails to improve patients with multifocal motor neuropathies and antibodies to gangliosides. J Neurol Neurosurg Psychiatry 1992;55:857-858
33. Leger JM, Younes-Chennoufi A, Chassande B, et al. Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry 1994;57:S46-S49
34. Dalakas M, Stein D, Otero C, Sekul E, Cupler E, McCrosky S. Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy. Arch Neurol 1994;51:861-864
35. Nobile-Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993;43:537-544
36. Chaudhry V, Corse A, Cornblath D, et al. Multifocal motor neuropathy: responses to human immune globulin. Ann Neurol 1993;33:237-242
37. Federico P, Zochodne DW, Hahn A, Brown WF, Feasby TE. Multifocal motor neuropathy improved by IVIg: randomized, double blind, placebo controlled study. Neurology 2000;55:1256-1262
38. Van den Berg LH, Kerkhoff H, Oey PL, et al. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1995;59:248-252
39. Azulay J-P, Blin O, Pouget J, et al. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM antibodies: a double-blind, placebo controlled study. Neurology 1994;44:429-432
40. Brannagan T. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune mediated neuropathies. Neurology 2002;59:S33-S40
41. Meucci N, Cappellari A, Barbieri S, Scarlato G, Nobile-Orazio E. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 1997;63:765-769
42. Stangel M, Hartung HP, Marx P, Gold R. Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci 1998;153:203-214
43. Van den Berg-Vos RM, Franssen H, Wokke JH, Van Es W, Van den berg LH. Multifocal motor neuropathy: diagnostic criteria that predict the response to treatment. Ann Neurol 2000;48:919-926
44. Katz, JS, Barohn RJ, Kojan S, et al. Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology 2002;58:615-620
45. Ellis CM, Leary S, Payan J, et al. Use of human intravenous immunoglobulin in lower motor neuron syndromes. J Neurol Neurosurg Psychiatry 1999;67:15-19
46. Pakiam A, Parry G. Multifocal motor neuropathy without overt conduction block. Muscle Nerve 1998;21:243-245
47. Pestronk A, Lopate G, Kornberg AJ, et al. Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide. Neurology 1994;44:2027-2031
48. Dalakas MC. Intravenous immune globulin therapy for neurological diseases. Ann Intern Med 1997;126:721-730
49. National Institute of Health Consensus Conference. Intravenous immunoglobulin prevention and treatment of disease. JAMA 1990;264:3189-3193
50. Brannagan T, Nagle K, Lange D, Rowland L. Complications of intravenous immune globulin treatment in neurologic disease. Neurology 1996;47:674-677
51. Bertorini TE, Nance AM, Horner LH, Greene W, Gelfand MS, Jaster JH. Complications of intravenous gammaglobulin in neuromuscular and other disease. Muscle Nerve 1996;19:388-391
52. Dalakas MC. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology 2002;59:S13-S21
53. Caress J, Cartwright M, Donofrio P, Peacock J. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology 2003;60:1822-1824
54. Go RS, Call TG. Deep vein thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin Proc 2000;75:83-85
55. Elkayam O, Paran D, Milo R, et al. Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases. Ann Rheum Dis 2000;59:77-80
56. Stangel M, Hartung HP, Marx P, Gold R. Side effects of high dose intravenous immunoglobulins. Clin Neuropharmacol 1997;20:358-393
57. Koski C. Therapy of CIDP and related immune-mediated neuropathies. Neurology 2002;59:S22-S27
58. Feldman EL, Bromberg MB, Albers JW, Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 1991;30:397-401
59. Van den Berg-Vos RM, Van den Berg LH, Franssen H, Van Doorn PA, Merkies ISJ, Wokke JHJ. Treatment of multifocal motor neuropathy with interferon-beta1A. Neurology 2000;54:1518-1521
60. Martina ISJ, van Doorn PA, Schmitz PIM, Meulstee J, van der Meche FGA. Chronic motor neuropathies: response to interferon-β1A after failure of conventional therapies. J Neurol Neurosurg Psychiatry 1999;66:197-201
61. Levine T, Pestronk A. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab. Neurology 1999;52:1701-1704
62. Pestronk A, Florence J, Miller T, Choksi R. Al-Lozi MT, Levine TD. Treatment with IgM antibody associated polyneuropathies using rituximab. J Neurol Neurosurg Psychiatry 2003;74:485-489
63. Van den Berg-Vos RM, Franssen H, Wokke JH, Van den Berg LH. Multifocal motor neuropathy: long term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain 2002;125:875-1886
64. Van den Berg LH, Franssen H, Wokke JH. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain 1998;121:421-428
65. Elliot J, Pestronk A. Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin. Neurology 1994;44:9667-9668
66. Azulay JP, Rihet P, Pouget J, et al. Long term follow up of multifocal motor neuropathy under treatment. J Neurol Neurosurg Psychiatry 1997;62:391-394